FR1: A Protein Involved in Cell Signaling and Cancer & Inflammation

Target Name: Frizzled Receptor

NCBI ID: P16169

Other Name(s): None

FR1: A Protein Involved in Cell Signaling and Cancer & Inflammation

Frizzled Receptor (FR) is a protein that is expressed in various tissues throughout the body. It plays a crucial role in cell signaling, particularly in the regulation of cell growth and differentiation. The FR family of proteins consists of four isoforms, FR1-3 . In this article, we will focus on FR1, which is a protein that is known to be a drug target and a potential biomarker.

FR1 is a 21-kDa protein that is expressed in the brain, heart, and pancreas. It is involved in the regulation of cell signaling pathways, including the TGF-β pathway. TGF-β is a well-known growth factor that plays a crucial role in the development and maintenance of tissues. The TGF-β pathway is a complex signaling pathway that is involved in the regulation of cell growth, differentiation, and survival.

FR1 is a key regulator of TGF-β signaling in the brain. It is research shows that FR1 plays a critical role in the regulation of neuronal differentiation and the maintenance of neuronal stem cells. In addition, FR1 is also involved in the regulation of synaptic plasticity , which is the ability of neurons to change and adapt in response to various stimuli.

FR1 is also a potential biomarker for various diseases, including cancer. The overexpression of FR1 has been observed in various types of cancer, including breast, ovarian, and colorectal cancer. Additionally, it has also been shown to be involved in the regulation of cancer cell migration and invasion.

Another potential drug target for FR1 is the regulation of inflammation. Studies have shown that FR1 is involved in the regulation of inflammation and immune responses. It is expressed in various immune cells, including dendritic cells, macrophages, and T cells. Additionally, it is involved in the regulation of inflammation-related signaling pathways, including the TLR signaling pathway.

In conclusion, FR1 is a protein that is known to be involved in various signaling pathways that are involved in cell growth, differentiation, and survival. It is a potential drug target and biomarker for various diseases, including cancer and inflammation. Further research is needed to fully understand the role of FR1 in these processes and to develop effective treatments.

Protein Name: Frizzled Receptor (nonspecified Subtype)

More Common Targets